Cronobacter and Salmonella were recently found in powdered baby formulas produced by Abbott at a facility in Michigan, leading to an FDA warning and voluntary recall.
The bacteria present in the baby formula led to infections in babies who consumed certain powdered formulas.
Infections in babies were from both Cronobacter and Salmonella.
The FDA is advising consumers not to use Similac, Alimentum, or EleCare powdered infant formulas if:
- The first two digits of the code are 22 through 37; and
- The code on the container contains K8, SH or Z2; and
- The expiration date is 4-1-2022 (APR 2022) or later
The original recall, put out on February 17th, has been expanded following the death of a second child.
Complaints Filed Against Powdered Abbott Laboratories
Just days before the expanded recall was announced and mere weeks after the original recall, a February 25th class action complaint was filed in the U.S. District Court: Northern District of Illinois.
The complaint alleges that Abbott Laboratories:
“Negligently failed to exercise reasonable care in the formulation, design, manufacturing, promotion, marketing, advertising, packaging, labeling, distribution and/or sale of certain infant powdered formula products.”
Another complaint, filed in the U.S. District Court: Southern District of Florida on February 20th, contains similar allegations.
The complaint alleges that Abbott engaged in:
“Numerous unfair and deceptive acts and practices designed to mislead the public in connection with their promotion, marketing, advertising, packaging, labeling, distribution and/or sale of Similac Infant Formula…”
The complaint continues, saying that:
“Defendants unfairly and deceptively promoted [Similac Infant Formula] during the relevant time period as containing ingredients safe for infant consumption and being safe for use, when, in fact, they cause bacterial infections and gastrointestinal illnesses such as Cronobacter sakazakii, Salmonella, diarrhea, gastrointestinal illnesses, and other serious health problems.”
As time goes on and more evidence begins to mount, further legal action is expected to be taken against Abbott and other baby formula manufacturers.